Showing results (121-130 of 333) with videos related to
Sort By:
Pageof 34
Journal of the American Geriatrics Society|November 9, 2012
Missing drivers with dementia: antecedents and recoveryMeredeth A Rowe, Catherine A Greenblum, Marie Boltz, et al.Journal of Alzheimer'S Disease Reports|March 9, 2023
Mindfulness and Care Experience in Family Caregivers of Persons Living with DementiaMagdalena I Tolea, Simone Camacho, Iris R Cohen, et al.Neurology|December 13, 2006
Survival and mortality differences between dementia with Lewy bodies vs Alzheimer diseaseMonique M Williams, Chengjie Xiong, John C Morris, et al.Plos One|May 31, 2019
End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregiversMelissa J Armstrong, Slande Alliance, Angela Taylor, et al.Sleep|September 4, 2009
Persistent short-term memory defects following sleep deprivation in a drosophila model of Parkinson diseaseLaurent Seugnet, James E Galvin, Yasuko Suzuki, et al.Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
MethylCog predicts six-year cognitive ability beyond blood-based ADRD biomarkersDeirdre M O'Shea, Lily Wang, David Lukacsovich, et al.Molecular Immunology|April 3, 2001
Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodiesN M Mertens, J E Galvin, E E Adderson, et al.Neurology and Therapy|April 7, 2025
The Cognivue Amyloid Risk Measure (CARM): A Novel Method to Predict the Presence of Amyloid with Cognivue ClarityJames E Galvin, Michael J Kleiman, Heather M Harris, et al.Acta Biomaterialia|April 24, 2017
A strain-mediated corrosion model for bioabsorbable metallic stentsE Galvin, D O'Brien, C Cummins, et al.Experimental Neurology|March 22, 2001
Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigraJ E Galvin, T M Schuck, V M Lee, et al.Pageof 34